A case of Thrombotic Thrombocytopenic Purpura following the AstraZeneca Vaccine
Journal of Ardabil University of Medical Sciences(2022)
Abstract
A severe acute respiratory syndrome caused by coronavirus 2 infection (COVID-19)was identified in December 2019 and caused a massive pandemic that claimed millions of lives worldwide. The Chimpanzee adenovirus vector vaccine is one of the few vaccines against coronavirus disease in 2020. This case report introduces, a patient who developed thrombocytopenia, fever, and lethargy nine days after vaccination with the chimpanzee adenovirus carrier vaccine. The patient was admitted to the hospital and thrombotic thrombocytopenic purpura (TTP) symptoms appeared during hospitalization.
MoreTranslated text
Key words
thrombotic thrombocytopenic purpura,vaccine,chadox1,covid-19,azd-1222
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined